Core Viewpoint - The company, Chutian Technology, is focusing on the development of pharmaceutical robots that align with the core pharmaceutical equipment industry chain, aiming for automation and intelligence in pharmaceutical production [1] Summary by Relevant Categories Business Strategy - The company is concentrating on the clean medical core sector to promote the upgrade of pharmaceutical equipment towards unmanned and intelligent solutions, which aligns with future trends in pharmaceutical production [1] Product Development - Chutian Technology has successfully developed and implemented clean robots and sorting robots, which are adaptable to existing business scenarios [1] Competitive Advantage - The company's core competitive advantages lie in two areas: a deep understanding of the application scenarios of its business segments and a profound comprehension of the production processes in the downstream pharmaceutical industry, enabling precise matching of current pharmaceutical equipment needs [1]

Group 1: Financial Performance - The company expects a significant turnaround in 2025, with a substantial increase in net profit and net profit excluding non-recurring items compared to 2024, driven by international market expansion and cost control measures [2][3] - The overall operating costs were effectively controlled in 2025, with total expenses significantly reduced compared to the same period in 2024 [3] Group 2: Market Expansion - The company has made breakthroughs in overseas markets, particularly in Southeast Asia, the Middle East, and the Americas, leading to a notable increase in the proportion of international business in overall operations [2][4] - The international sales and service team has expanded, establishing localized sales and service points in over 20 key countries and regions [4] Group 3: Product Development and Innovation - The company has consistently focused on technological innovation, with R&D investment among the highest in the industry, launching new products such as continuous BFS and fully automated inspection machines [7] - Future strategies will continue to prioritize dual advancements in product technology and manufacturing technology, enhancing overall solution capabilities for clients in the pharmaceutical industry [7] Group 4: Strategic Outlook for 2026 - The company aims to further expand its overseas market presence, capitalizing on the growth and high-end transformation trends in the domestic pharmaceutical equipment industry [8] - Management strategies will focus on quality improvement and efficiency enhancement through smart manufacturing and cost control measures [8]